Beam Therapeutics Inc.

US$26.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BEAMHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 2.43%
Div yield —
ROE (11.29%)
Biotechnology
Beta (5Y) 2.22
PE TTM —
TSR TTM 5.60%
Mkt cap US$2.632B
ROIC (21.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$34
27.07%
(20.28%)
Hold 4|11|6|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.28
0.27
0.29
4.88%
10.92%
(3.23%)
7.96%
Revenue$M
137.8
143.2
150.1
151.2
1.01%
4.68%
11.58%
7.37%
Peers (US$2.632B)
Cap (US$)
PE
2.683B
—
Capital
TTM
5Y
10Y
Leveragex
8.145
(0.012)
(0.010)
EBIT/Intx
9.585
0.085
0.087
Own earn%
(29.21)
44.50
31.28
Sh yield%
49.17
44.46
44.14
Owners
Insiders/Inst%
12.31
33.56
Short interest%
2.80
SBC / revenue%
1.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
23–30
$1 testx
0.0
Incr. ROIC%
48